+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Autoinjectors Market By Type, By Application, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5233786
  • Report
  • December 2020
  • Region: Europe
  • 97 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie, Inc.
  • Amgen, Inc.
  • Biogen, Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC (GSK)
  • Merck Group
The Europe Autoinjectors Market is expected to witness market growth of 17.1% CAGR during the forecast period (2020-2026).

Auto-injectors have numerous advantages like they lessen phobia and anxiety related to needles, decrease chances of a needle stuck incidences, keep the consistency of dose precision, and also help with better efficiency, which, in turn, support growth. Drug delivery by using an auto-injector is more controlled than manual injection.

The administration site of any drug is chosen on the basis of the nature of the drug; however, it is usually administered intramuscularly. Autoinjectors, if compared to syringes, are less painful, thus demand is increasing. Though, the availability of substitutes like oral tablets may obstruct growth.

In a reasonably short time period, the market for self-injection devices has full-fledged into a conspicuous and promising segment in the pharmaceutical industry. Autoinjectors are one such device that has witnessed amplified adoption among patients, particularly for the treatment of emergency situations like anaphylactic shocks. As per the developers, these devices are quite easier to use as compared to parenteral drug delivery systems and have incorporated needle-safety features. It has been proved that the autoinjectors have resolved a number of issues faced by patients such as injection-related tolerability.

Based on Type, the market is segmented into Disposable autoinjectors and Reusable autoinjectors. Based on Application, the market is segmented into Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications. Based on End Use, the market is segmented into Hospitals & Clinics and Home care settings. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, GlaxoSmithKline PLC (GSK), Merck Group, Sanofi S.A., Becton, Dickinson and Company, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., Ypsomed AG, AbbVie, Inc. and Biogen, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type
  • Disposable autoinjectors
  • Reusable autoinjectors
By Application
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Other Applications
By End Use
  • Hospitals & Clinics
  • Home care settings
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Eli Lilly and Company
  • GlaxoSmithKline PLC (GSK)
  • Merck Group
  • Sanofi S.A.
  • Becton, Dickinson and Company
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • Ypsomed AG
  • AbbVie, Inc.
  • Biogen, Inc.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie, Inc.
  • Amgen, Inc.
  • Biogen, Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC (GSK)
  • Merck Group
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Autoinjectors Market, by Type
1.4.2 Europe Autoinjectors Market, by Application
1.4.3 Europe Autoinjectors Market, by End Use
1.4.4 Europe Autoinjectors Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, May - 2020, Nov) Leading Players

Chapter 4. Europe Autoinjectors Market by Type
4.1 Europe Disposable autoinjectors Market by Country
4.2 Europe Reusable autoinjectors Market by Country

Chapter 5. Europe Autoinjectors Market by Application
5.1 Europe Anaphylaxis Market by Country
5.2 Europe Rheumatoid Arthritis Market by Country
5.3 Europe Multiple Sclerosis Market by Country
5.4 Europe Other Application Market by Country

Chapter 6. Europe Autoinjectors Market by End Use
6.1 Europe Hospitals & Clinics Autoinjectors Market by Country
6.2 Europe Home care settings Autoinjectors Market by Country

Chapter 7. Europe Autoinjectors Market by Country
7.1 Germany Autoinjectors Market
7.1.1 Germany Autoinjectors Market by Type
7.1.2 Germany Autoinjectors Market by Application
7.1.3 Germany Autoinjectors Market by End Use
7.2 UK Autoinjectors Market
7.2.1 UK Autoinjectors Market by Type
7.2.2 UK Autoinjectors Market by Application
7.2.3 UK Autoinjectors Market by End Use
7.3 France Autoinjectors Market
7.3.1 France Autoinjectors Market by Type
7.3.2 France Autoinjectors Market by Application
7.3.3 France Autoinjectors Market by End Use
7.4 Russia Autoinjectors Market
7.4.1 Russia Autoinjectors Market by Type
7.4.2 Russia Autoinjectors Market by Application
7.4.3 Russia Autoinjectors Market by End Use
7.5 Spain Autoinjectors Market
7.5.1 Spain Autoinjectors Market by Type
7.5.2 Spain Autoinjectors Market by Application
7.5.3 Spain Autoinjectors Market by End Use
7.6 Italy Autoinjectors Market
7.6.1 Italy Autoinjectors Market by Type
7.6.2 Italy Autoinjectors Market by Application
7.6.3 Italy Autoinjectors Market by End Use
7.7 Rest of Europe Autoinjectors Market
7.7.1 Rest of Europe Autoinjectors Market by Type
7.7.2 Rest of Europe Autoinjectors Market by Application
7.7.3 Rest of Europe Autoinjectors Market by End Use

Chapter 8. Company Profiles
8.1 Eli Lilly and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Geographical Expansions:
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.1 Recent strategies and developments:
8.2.1.1 Approvals:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Sanofi S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Approvals:
8.4.5.3 Product Launches and Product Expansions:
8.5 Becton, Dickinson and Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Approvals:
8.7 Amgen, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Research & Development Expense
8.7.4 Recent strategies and developments:
8.7.4.1 Product Launches and Product Expansions:
8.8 Ypsomed AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 AbbVie, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.10. Biogen, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
Note: Product cover images may vary from those shown
  • Eli Lilly and Company
  • GlaxoSmithKline PLC (GSK)
  • Merck Group
  • Sanofi S.A.
  • Becton, Dickinson and Company
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • Ypsomed AG
  • AbbVie, Inc.
  • Biogen, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll